Clinical Trial Update: A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing objective endpoint measurements for bacterial skin infections; completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin and Subcutaneous Tissue Bacterial Infections

Snippet

Sponsor: Melinta Therapeutics, Inc. | Conditions: Skin and Subcutaneous Tissue Bacterial Infections | Phase 2 | Status: COMPLETED | Results posted: 2013-10-29